Business
Vortex Biosciences' CSO Wins SLAS Innovation Award
Vortex Biosciences' CSO Wins SLAS Innovation Award.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 8913W NetScientific PLC 15 February 2017 \n\n \n \nNetScientific plc\n(\"NetScientific\" or the \"Company\")\n \nVortex Biosciences' Chief Scientific Officer, Elodie Sollier Awarded 2017 SLAS Innovation Award\n \nLondon, UK - 15 February 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that the Chief Scientific Officer of its portfolio company, Vortex Biosciences, Elodie Sollier-Christen, has been awarded a 2017 Society for Laboratory Automation and Screening (SLAS) Innovation Award. \nElodie's presentation to the judges: \"Vortex Technology for fast and label-free isolation of circulating tumour cells from blood samples\", where she discussed a breakthrough by Vortex in the isolation of circulating tumour cells from blood samples, is now available to view on the SLAS website (www.slas.org).\nThe annual SLAS Innovation Award recognizes extraordinary achievement in innovative life sciences discovery and technology. All those selected to deliver podium presentations at the annual SLAS conference are eligible to be considered for this award, which comes with a $10,000 prize.\nCommenting on the news, François R. Martelet, Chief Executive Officer of NetScientific, said: \"We wish to extend our warm congratulations to Elodie on her receipt of this prestigious award. We view this prize as a recognition of her extraordinary work on the cutting edge technology utilised by Vortex on the design of the VTX-1 Liquid Biopsy System. We believe that this technology has great potential to significantly impact laboratory automation and screening and we are delighted to see it receive due recognition.\"\n \nThe full text of the announcement is below:\n \n \nCSO of Vortex Biosciences Dr. Elodie Sollier-Christen Awarded With 2017 SLAS Innovation Award\n \nDr. Elodie Sollier-Christen's Presentation on the Development of the VTX-1 Liquid Biopsy System Recognized for Innovation and Impact to Research \n \nMENLO PARK, CA, 14 February 2017 - Vortex Biosciences, provider of circulating tumor cell (CTC) capture systems, congratulates Chief Scientific Officer (CSO) Dr. Elodie Sollier-Christen for receiving the Innovation Award at SLAS 2017, the annual conference and exhibition of the Society for Laborator...